Study Notes on the Systematic Review of the Serotonin Theory of Depression

SYSTEMATIC REVIEW OF THE SEROTONIN THEORY OF DEPRESSION

Introduction

  • Definition of the serotonin theory of depression:
    • Suggests that abnormalities in serotonin levels contribute to depression, influencing the justification for antidepressant use.
    • The theory gained prominence in the 1960s and was further publicized with SSRIs in the 1990s.

Objectives of the Review

  • Aim: To evaluate evidence connecting depression with lowered serotonin levels or activity through a systematic umbrella review.
  • Research focus areas:
    1. Serotonin and serotonin metabolite (5-HIAA) concentrations in body fluids.
    2. 5-HT1A receptor binding levels.
    3. Serotonin transporter (SERT) levels (via imaging or autopsy).
    4. Tryptophan depletion studies.
    5. SERT gene associations.
    6. SERT gene-environment interactions.
  • Exclusion criteria:
    • Studies with depressed individuals with physical conditions or specific depression types (e.g., bipolar disorder).

Methodology

  • Databases searched: PubMed, EMBASE, PsycINFO until December 2020.
  • Review process:
    • Two independent reviewers extracted data and evaluated quality using AMSTAR-2 or modified GRADE for genetic studies.
    • The review is registered with PROSPERO (CRD42020207203).

Study Characteristics

  • Seventeen studies included (12 systematic reviews/meta-analyses, 1 narrative synthesis, 1 genetic association study).
  • Quality ratings varied; some genetic studies were of high quality.

Findings

Serotonin and 5-HIAA

  • Meta-analyses showed no significant association between depression and serotonin/5-HIAA concentrations.
    • Largest meta-analysis sample: 1002 participants.
    • Results showed lowered levels of serotonin were associated with antidepressant use rather than depression itself.

5-HT1A Receptor Binding

  • Two meta-analyses indicated weak, inconsistent evidence for altered 5-HT1A receptor binding in depressed individuals:
    • Largest sample size: 561 participants.
  • Findings suggest possible increased serotonin availability in depression.

Serotonin Transporter (SERT) Binding

  • Three meta-analyses indicate reductions in SERT binding across various brain regions:
    • Largest sample size: 1845 participants.
  • Prior antidepressant use effects were not consistently excluded.

Tryptophan Depletion Studies

  • Majority of studies found no significant effect on mood from tryptophan depletion in healthy individuals:
    • Total sample size across analyses: 566.
  • Weak evidence of mood effects in small samples with a family history of depression.

Genetic Associations

  • Two comprehensive genetic studies found no evidence connecting SERT gene variations with depression:
    • Largest sample sizes: 115,257 and 43,165.
  • No significant interaction between genetic variants and stress in contributing to depression.

Conclusions

  • Overall findings indicate no reliable connection between serotonin activity/levels and depression.
  • Some evidence suggests long-term antidepressant use may actually lower serotonin levels.
  • The belief in the serotonin theory persists among the public and practitioners despite the lack of empirical support.

Data Availability

  • All extracted data can be found in the supporting materials of the publication.

References

  • References cited to support claims, methods, and findings throughout the study, including leading studies on serotonin and depression.

Author Contributions

  • Contributions of each author to study conception, design, execution, and manuscript preparation are detailed, emphasizing a collaborative approach.